Publications

This folder holds the following references to publications, sorted by year and author.

There are 76 references in this bibliography folder.

Robert-Paganin, J, Rety, S, and Leulliot, N (2015).
Regulation of DEAH/RHA helicases by G-patch proteins.
Biomed Res Int, 2015:931857.

Turpin, J, Journo, C, Ko, NL, Sinet, F, Carpentier, A, Galioot, A, Edwards, D, Vandamme, A, Gazzolo, L, Duc Dodon, M, Gessain, A, Kashanchi, F, Balansard, I, Lacoste, R, and Mahieux, R (2015).
Discovery and characterization of auxiliary proteins encoded by type 3 simian T-cell lymphotropic viruses.
J Virol, 89(2):931-51.

Karam, M, Thenoz, M, Capraro, V, Robin, J, Pinatel, C, Lancon, A, Galia, P, Sibon, D, Thomas, X, Ducastelle-Lepretre, S, Nicolini, F, El-Hamri, M, Chelghoun, Y, Wattel, E, and Mortreux, F (2014).
Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
Neoplasia, 16(1):21-30.

Larocque, E, Andre-Arpin, C, Borowiak, M, Lemay, G, Switzer, WM, Duc Dodon, M, Mesnard, J, and Barbeau, B (2014).
Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.
J Virol, 88(16):8956-70.

Borowiak, M, Kuhlmann, A, Girard, S, Gazzolo, L, Mesnard, J, Jalinot, P, and Dodon, MD (2013).
HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene.
Carcinogenesis, 34(11):2664-72.

Cachat, A, Villaudy, J, Rigal, D, Gazzolo, L, and Duc Dodon, M (2012).
[Mice are not Men and yet... how humanized mice inform us about human infectious diseases].
Med Sci (Paris), 28(1):63-8.

Macaire, H, Riquet, A, Moncollin, V, Biemont-Trescol, M, Duc Dodon, M, Hermine, O, Debaud, A, Mahieux, R, Mesnard, J, Pierre, M, Gazzolo, L, Bonnefoy, N, and Valentin, H (2012).
Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
J Biol Chem, 287(25):21357-70.

Mocquet, V, Neusiedler, J, Rende, F, Cluet, D, Robin, J, Terme, J, Duc Dodon, M, Wittmann, J, Morris, C, Le Hir, H, Ciminale, V, and Jalinot, P (2012).
The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.
J Virol, 86(14):7530-43.

Morris, C, Tomimatsu, N, Richard, DJ, Cluet, D, Burma, S, Khanna, KK, and Jalinot, P (2012).
INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells.
Cancer Res, 72(8):2006-16.

Neusiedler, J, Mocquet, V, Limousin, T, Ohlmann, T, Morris, C, and Jalinot, P (2012).
INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation.
RNA, 18(6):1163-77.

Nambotin, SB, Lefrancois, L, Sainsily, X, Berthillon, P, Kim, M, Wands, JR, Chevallier, M, Jalinot, P, Scoazec, J, Trepo, C, Zoulim, F, and Merle, P (2011).
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma.
J Hepatol, 54(2):288-99.

Duc Dodon, M, Mesnard, J, and Barbeau, B (2010).
[Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
Med Sci (Paris), 26(4):391-6.

Planel, S, Salomon, A, Jalinot, P, Feige, J, and Cherradi, N (2010).
A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.
Oncogene, 29(45):5989-6003.

Terme, J, Lhermitte, L, Asnafi, V, and Jalinot, P (2009).
TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
Blood, 113(26):6695-8.

Terme, J, Mocquet, V, Kuhlmann, A, Zane, L, Mortreux, F, Wattel, E, Duc Dodon, M, and Jalinot, P (2009).
Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
Leukemia, 23(11):2081-9.

Wencker, M, Gazzolo, L, and Duc Dodon, M (2009).
The leukemogenic activity of TaxHTLV-1 during human alphabeta T cell development.
Front Biosci (Schol Ed), 1:194-204.

Terme, J, Wencker, M, Favre-Bonvin, A, Bex, F, Gazzolo, L, Duc Dodon, M, and Jalinot, P (2008).
Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
J Virol, 82(16):7913-22.

Vitte, A and Jalinot, P (2008).
Intracellular delivery of peptides via association with ubiquitin or SUMO-1 coupled to protein transduction domains.
BMC Biotechnol, 8:24.

Buchsbaum, S, Morris, C, Bochard, V, and Jalinot, P (2007).
Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.
Oncogene, 26(35):5132-44.

Kuhlmann, A, Villaudy, J, Gazzolo, L, Castellazzi, M, Mesnard, J, and Duc Dodon, M (2007).
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).
Retrovirology, 4:92.

Morris, C, Wittmann, J, Jack, H, and Jalinot, P (2007).
Human INT6/eIF3e is required for nonsense-mediated mRNA decay.
EMBO Rep, 8(6):596-602.

Molle, V, Zanella-Cleon, I, Robin, J, Mallejac, S, Cozzone, AJ, and Becchi, M (2006).
Characterization of the phosphorylation sites of Mycobacterium tuberculosis serine/threonine protein kinases, PknA, PknD, PknE, and PknH by mass spectrometry.
Proteomics, 6(13):3754-66.

Vitte, A, Buchsbaum, S, and Jalinot, P (2006).
Modulation of HIV-1 Rev protein abundance and activity by polyubiquitination with unconventional Lys-33 branching.
FEBS Lett, 580(26):6155-60.

Favre-Bonvin, A, Reynaud, C, Kretz-Remy, C, and Jalinot, P (2005).
Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.
J Virol, 79(7):4229-37.

Morris, C and Jalinot, P (2005).
Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B-Cdk1 activation.
Oncogene, 24(7):1203-11.

Roisin, A, Robin, J, Dereuddre-Bosquet, N, Vitte, A, Dormont, D, Clayette, P, and Jalinot, P (2004).
Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev.
J Biol Chem, 279(10):9208-14.